Jeffrey Cofie
Optometrist · Warner Robins, GANPI 1205316296
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Johnson & Johnson Vision Care, Inc. accounts for 88.3% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $57,908, more than ten times the $391 reported in 2019. Among optometrist clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 343 payments — averaging $270.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$82K
- Alcon$3K
- Bausch & Lomb Americas Inc.$2K
- Tarsus Pharmaceuticals, Inc.$864
- Harrow Eye, LLC$683
- Sun Pharmaceutical Industries Inc.$603
- plus $4K from 15 others
What the payments were for
- Consulting fees$7,0178%
- Speaking & faculty fees$54,10058%
- Travel & lodging$17,20019%
- Food & beverage$14,49816%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 203 | $81,918 |
| Alcon | 39 | $2,974 |
| Bausch & Lomb Americas Inc. | 20 | $1,999 |
| Tarsus Pharmaceuticals, Inc. | 12 | $864 |
| Harrow Eye, LLC | 8 | $683 |
| Sun Pharmaceutical Industries Inc. | 6 | $603 |
| Glaukos Corporation | 5 | $545 |
| Biotissue Holdings Inc. | 9 | $388 |
| Dompe US, Inc. | 5 | $370 |
| Coopervision Inc. | 8 | $345 |
| Sight Sciences, Inc. | 4 | $276 |
| AbbVie(2 entities) | 4 | $264 |
| Aerie Pharmaceuticals, Inc. | 3 | $256 |
| Eyevance Pharmaceuticals LLC | 2 | $245 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $240 |
| Apellis Pharmaceuticals, Inc. | 2 | $234 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $178 |
| Amgen | 2 | $148 |
| Kala Pharmaceuticals, Inc. | 2 | $144 |
| Novartis | 2 | $121 |
| Oyster Point Pharma, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$78,517
- MIEBO$1,204
- XDEMVY$612
- XIIDRA$470
- Rhopressa$468
- Rocklatan$468
- CEQUA$438
- VEVYE$370
- Oxervate$359
- INFUSE$240
- VYZULTA$239
- Syfovre$234
- MyDay Contact Lens$230
- Flarex$161
- Photrexa Viscous and Photrexa$155
- TEARCARE SYSTEM$154
- CE-marked KXLA system$149
- AMO PHACO NEEDLE$140
- ULTRA MULTIFOCAL TORIC$124
- TRYPTYR$123
How this compares
$92,815 in reported general payments places this provider in the 95th percentile of 1,285 optometrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in Warner Robins
- Joshua JohnstonAtlanta$993K
- John WomackCanton$931K
- Naheed AhmadRoswell$296K
- Scott MoscowRoswell$278K
- Stephen SummerowPerry$222K
- Janelle DavisonSmyrna$199K
- Keyle BrownDawsonville$182K
- Nacondus GambleFort Stewart$175K
- Amber ZaunbrecherAtlanta$99K
- Emily LoveAtlanta$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.